Hormone Replacement Therapy and Haemostatic Function
- 1 June 1997
- journal article
- review article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 78 (01) , 765-769
- https://doi.org/10.1055/s-0038-1657626
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Hormone replacement therapy and risk of venous thromboembolism: population based case-control studyBMJ, 1997
- Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogensThe Lancet, 1996
- Risk of venous thromboembolism in users of hormone replacement therapyThe Lancet, 1996
- Prospective study of exogenous hormones and risk of pulmonary embolism in womenThe Lancet, 1996
- Case-control study of venous thromboembolism risk in users of hormone replacement therapyThe Lancet, 1996
- Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Third generation oral contraceptives and risk of myocardial infarction: an international case-control studyBMJ, 1996
- Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control studyBMJ, 1996
- Hormone Replacement Therapy and the Risk of StrokeArchives of internal medicine (1960), 1993
- The risk of acute myocardial infarction after oestrogen and oestrogen‐progestogen replacementBJOG: An International Journal of Obstetrics and Gynaecology, 1992